Angiotensin-(1-7) induced vascular relaxation in spontaneously hypertensive rats

Nitric Oxide. 2019 Jul 1:88:1-9. doi: 10.1016/j.niox.2019.03.007. Epub 2019 Mar 14.

Abstract

Enhanced vasoconstriction and decreased vasodilatation due to endothelial dysfunction contribute to the progression of hypertension. Angiotensin (Ang)-(1-7) plays important roles in regulating the cardiovascular activity. The current study aimed to investigate the roles of Ang-(1-7) in modulating blood pressure, vascular tension and its signal pathway in spontaneously hypertensive rats (SHR). The effects of intravenous injection of drugs were determined in rats with anesthesia in vivo. Mesenteric artery (MA), coronary artery (CA) and pulmonary artery (PA) were isolated from rats and isometric tension measurements in arteries were performed. Compared with Wistar-Kyoto rats (WKY), the high K+ induced vasoconstriction was enhanced and acetylcholine-induced vasodilatation were attenuated in the MA, CA and PA in SHR. Intravenous injection of Ang-(1-7) decreased, while A-779 increased mean arterial pressure and abolished the hypotensive effect of Ang-(1-7) in SHR. Ang-(1-7) caused dose-dependent relaxation in MA, CA and PA in SHR, which was inhibited by pretreatment with Mas receptor antagonist A-779, nitric oxide (NO) synthase inhibitor l-NAME, guanylate cyclase inhibitor ODQ and protein kinase G (PKG) inhibitor DT-2. The Mas receptor expression, NO, cGMP and PKG levels of the three above arteries of SHR were lower than that of WKY. Ang-(1-7) increased the NO, cGMP and PKG levels in arteries from SHR, which was blocked by A-779. Activation of the Mas receptor by Ang-(1-7) relaxes the MA, CA, and PA through the NO-cGMP-PKG pathway, which contributes to the decrease of arterial pressure in SHR.

Keywords: Angiotensin-(1-7); Hypertension; Nitric oxide; Vascular tension; cGMP-PKG signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / pharmacology*
  • Angiotensin II / analogs & derivatives
  • Angiotensin II / pharmacology
  • Animals
  • Arterial Pressure / drug effects
  • Coronary Vessels / drug effects
  • Cyclic GMP / metabolism
  • Cyclic GMP-Dependent Protein Kinases / metabolism
  • Dose-Response Relationship, Drug
  • Male
  • Mesenteric Arteries / drug effects
  • Nitric Oxide / metabolism
  • Peptide Fragments / pharmacology*
  • Pulmonary Artery / drug effects
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Receptors, G-Protein-Coupled / antagonists & inhibitors
  • Receptors, G-Protein-Coupled / metabolism
  • Signal Transduction / drug effects
  • Vasodilation / drug effects*

Substances

  • 7-Ala-angiotensin (1-7)
  • Peptide Fragments
  • Receptors, G-Protein-Coupled
  • Angiotensin II
  • Nitric Oxide
  • Angiotensin I
  • Cyclic GMP-Dependent Protein Kinases
  • Cyclic GMP
  • angiotensin I (1-7)